Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Citalopram HBr

InhA, Func 59729-32-7
N° du produit ABIN3220415

Aperçu rapide pour Citalopram HBr (ABIN3220415)

Application

Inhibition Assay (InhA), Functional Studies (Func)
  • Fonction

    Citalopram hydrobromide belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Citalopram and its N-demethylated metabolites exist as a racemic mixture but its effects are largely due to the S-enantiomer, S-citalopram and S-demthylcitalopram. Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize α- or β-adrenergic, dopamine D2 or histamine H1 receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT1A and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT1A and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal function that leads to enhanced serotonergic neurotransmission. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache. Side effects generally occur within the first two weeks of therapy and are usually less severe and frequent than those observed with tricyclic antidepressants. Citalopram is approved for treatment of depression. Unlabeled indications include mild dementia-associated agitation in nonpsychotic patients, smoking cessation, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy. Citalopram has the fewest drug-drug interactions of the SSRIs.

    Attributs du produit

    Tradename: CELEXA
    Source of Compound: synthetic
    Target: Serotonin uptake inhibitor,AChR antagonist,Adrenergic Receptor antagonist,Histamine Receptor
    Receptor: Sodium-dependent serotonin transporter,Muscarinic AChR,α-adrenergic receptor,Histamine H1 receptor

    Purification

    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.

    Pureté

    98 %

    Formula

    C20H21FN2O.HBr

    Solubility

    sparingly soluble in water
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Solid

    Stock

    -20 °C

    Stockage commentaire

    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.

    Date de péremption

    24 months
  • Sujet

    Neuroscience

    Poids moléculaire

    405.31 g/mol

    Numéro CAS

    59729-32-7
Vous êtes ici:
Chat with us!